D-803-2013 Class III Terminated

Recalled by Teva Pharmaceuticals USA, Inc. — Sellersville, PA

FDA drug recall D-803-2013 was initiated by Teva Pharmaceuticals USA, Inc. on Jun 18, 2013 and is designated Class III. Reason for recall: Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050. The recall status is terminated (terminated Dec 24, 2013). Affected quantity: 109,080 Bottles.

Recall details

Product Type
Drugs
Report Date
Jul 24, 2013
Initiation Date
Jun 18, 2013
Termination Date
Dec 24, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
109,080 Bottles

Product description

Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960.

Reason for recall

Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.

Distribution pattern

Nationwide

Code information

Lot #s: a) 35426557A, 35426558A, Exp 08/14; b) 35426554A, 35426555A, 35426556A, Exp 08/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-803-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-803-2013. Report a data issue: hello@regdatalab.com.